Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001214659-25-007881·TANG CAPITAL MANAGEMENT LLC
Schedule 13G ownership disclosure
Tarsus Pharmaceuticals Inc
Common Stock, par value $0.0001 per share · CUSIP: 87650L103
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLC
Shares: 2,454,797.00 · Class: 5.90%
- KEVIN TANG
Shares: 2,454,797.00 · Class: 5.90%
- TANG CAPITAL PARTNERS, LP
Shares: 2,334,439.00 · Class: 5.61%
- TANG CAPITAL PARTNERS INTERNATIONAL, LP
Shares: 62,358.00 · Class: 0.15%
- TANG CAPITAL PARTNERS III, INC
Shares: 43,500.00 · Class: 0.10%
- TANG CAPITAL PARTNERS IV, INC
Shares: 14,500.00 · Class: 0.04%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-007881
- Form type
- SCHEDULE 13G/A
- Filer
- TANG CAPITAL MANAGEMENT LLC
- CIK
- CIK 1232621
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership